Skip to main content
Clinical Trials/RPCEC00000212
RPCEC00000212CompletedPhase 4

Effectiveness and safety of Biograft-G in bone repair of the bucal complex. - EB-1

Biomaterials Center, University of Havana0 sitesStarted: March 11, 2016Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment

Eligibility Criteria

Ages
18 years to 75 years (—)
Sex
All

Inclusion Criteria

  • 1- Patients who meet the established diagnostic criteria.
  • 2- Age range between 18 and 75 years, both sexes, Cuban citizen without distinction of race.
  • 3- Outpatient whose health allows them to perform a normal physical activity without restrictions or light work.
  • 4- Patients that can be treated surgically.
  • 5- Patients give their written consent for participation to be included
  • 6- Patients with periodontal infra bony origin involved bone defects whose teeth have no mobility than Grade 2 according to Miller’s classification

Exclusion Criteria

  • 1- Diabetic patients decompensated or difficult to control.
  • 2- Immunocompromised or patients under immunosuppressive therapy.
  • 3- Mentally retarded.
  • 4- Patients with malignancies diagnosed, from any location.
  • 5- Patients who are pregnant.
  • 6- Patients with conditions of smoking and alcoholism.
  • 7- Patients with difficulties in tracking for residing in distant places.
  • 8- Patients who refuse to be included in the investigation.
  • 9- Patients with horizontal bone loss or periodontal defects supraóseos origin

Investigators

Sponsor
Biomaterials Center, University of Havana

Similar Trials